174 related articles for article (PubMed ID: 23143229)
1. APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38.
Moro ML; Giaccone G; Lombardi R; Indaco A; Uggetti A; Morbin M; Saccucci S; Di Fede G; Catania M; Walsh DM; Demarchi A; Rozemuller A; Bogdanovic N; Bugiani O; Ghetti B; Tagliavini F
Acta Neuropathol; 2012 Dec; 124(6):809-21. PubMed ID: 23143229
[TBL] [Abstract][Full Text] [Related]
2. Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.
Kumar-Singh S
Int J Mol Sci; 2009 Apr; 10(4):1872-1895. PubMed ID: 19468344
[TBL] [Abstract][Full Text] [Related]
3. Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse models.
Reinert J; Martens H; Huettenrauch M; Kolbow T; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Bayer TA; Wirths O
J Alzheimers Dis; 2014; 39(4):871-81. PubMed ID: 24305500
[TBL] [Abstract][Full Text] [Related]
4. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
5. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
[TBL] [Abstract][Full Text] [Related]
6. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.
Kulic L; McAfoose J; Welt T; Tackenberg C; Späni C; Wirth F; Finder V; Konietzko U; Giese M; Eckert A; Noriaki K; Shimizu T; Murakami K; Irie K; Rasool S; Glabe C; Hock C; Nitsch RM
Transl Psychiatry; 2012 Nov; 2(11):e183. PubMed ID: 23149447
[TBL] [Abstract][Full Text] [Related]
7. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
8. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
[TBL] [Abstract][Full Text] [Related]
9. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
10. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
[TBL] [Abstract][Full Text] [Related]
11. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
[TBL] [Abstract][Full Text] [Related]
12. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
13. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
[TBL] [Abstract][Full Text] [Related]
14. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
[TBL] [Abstract][Full Text] [Related]
17. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
[TBL] [Abstract][Full Text] [Related]
18. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
Frost JL; Le KX; Cynis H; Ekpo E; Kleinschmidt M; Palmour RM; Ervin FR; Snigdha S; Cotman CW; Saido TC; Vassar RJ; St George-Hyslop P; Ikezu T; Schilling S; Demuth HU; Lemere CA
Am J Pathol; 2013 Aug; 183(2):369-81. PubMed ID: 23747948
[TBL] [Abstract][Full Text] [Related]
19. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
[TBL] [Abstract][Full Text] [Related]
20. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.
Mann DM; Pickering-Brown SM; Takeuchi A; Iwatsubo T;
Am J Pathol; 2001 Jun; 158(6):2165-75. PubMed ID: 11395394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
